Show Notes
In this episode of The Good GP, host Dr Krystyna de Lange is joined by Dr Tegan Allin, rural generalist and GP obstetrician from Thursday Island live from the GP25 Conference, to discuss the topic of foetal rhesus screening and recent changes in Australian guidelines. They began with an overview of anti-D prophylaxis and its importance for women who are rhesus negative. Dr Tegan Allin explains the pathophysiology of rhesus disease, risks associated with sensitisation during pregnancy, and the traditional approach of universal prophylaxis with anti-D immunoglobulin. They then shift to the new availability of non-invasive prenatal screening (NIPS) for foetal rhesus status. Dr Tegan Allin describes how this serum-based test examines cell-free foetal DNA in maternal blood from 11 weeks gestation. With sensitivity and specificity over 99%, it allows for more targeted administration of anti-D only to those carrying a rhesus positive fetus.
Covering key practicalities of ordering foetal rhesus screening, including the appropriate gestational window (after 11 weeks and before 29 weeks), the importance of lab-specific request forms, and consideration of slight lab-to-lab differences in recommended timing.
Highlighting the ongoing changes in first trimester antenatal management and the need for GPs to remain up to date with evolving testing protocols. Reinforcing the necessity of confirming neonatal rhesus status at birth via cord blood testing, even when negative results are obtained antenatally.
The Good GP Podcast is a proud member of the Talking HealthTech Podcast Network - the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network
If you have any questions or would like to contact The Good GP, send an email to [email protected]. Visit www.thegoodgp.com.au for previous episodes and more information.
More from The Good GP
In this episode of The Good GP, Dr Krystyna de Lange speaks with Dr Steph Daly, GP with a special interest in aged care and dementia, about the introduction of plasma biomarkers, specifically the p-Tau 217 blood test for Alzheimer’s disease. They explore what the p-Tau 217 test measures, its reliability, and its role in primary care.
In this episode of The Good GP, host Dr Krystyna De Lange speaks with Dr David Leitinger, a GP with a special interest in addiction medicine, about the practical use of naltrexone for managing alcohol use disorder (AUD).
In this episode of The Good GP, Dr Julia Rawlinson speaks with Dr Florence Martin, an epidemiologist specialising in pregnancy pharmacoepidemiology. Dr Martin discusses her recent study examining the relationship between first trimester antidepressant use and miscarriage risk, using UK primary care data from the CPRD GOLD database.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Julia Feutrill, consultant psychiatrist at King Edward Memorial Hospital and co-director of the Elizabeth Clinic. They discuss the complexities of antidepressant use during pregnancy, providing GPs with practical advice for navigating these conversations.
In this episode of the Good GP, Dr Julia Rawlinson speaks with Dr Paul Effler, Senior Medical Advisor at the WA Department of Health and expert in communicable diseases, about H5N1 avian influenza and pertussis.